Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026)

Acadia Pharmaceuticals' (ACAD) quarterly Prepaid Assets came in at $64.6 million in Q1 2026, up 22.57% year-on-year from $52.7 million in Q1 2025, and up 8.52% quarter-over-quarter from $59.5 million in Q4 2025.

Acadia Pharmaceuticals (ACAD) Prepaid Assets (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $64.6 million for Q1 2026.

  • On a quarterly basis, Prepaid Assets rose 22.57% year-over-year to $64.6 million in Q1 2026; TTM through Mar 2026 was $64.6 million, a 22.57% increase from a year earlier, with the FY2025 full-year figure at $59.5 million, up 6.91% from the prior year.
  • Prepaid Assets grew to $64.6 million in Q1 2026 per ACAD's latest filing, from $59.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $64.6 million in Q1 2026 and bottomed at $21.0 million in Q2 2022.
  • The 5-year median for Prepaid Assets is $42.8 million (2024), against an average of $41.3 million.
  • Across the five-year window, Prepaid Assets fell 20.05% in 2022 and surged 92.74% in 2024, its largest moves.
  • Year by year, Prepaid Assets stood at $21.4 million in 2022, then surged by 82.69% to $39.1 million in 2023, then jumped by 42.44% to $55.7 million in 2024, then advanced by 6.91% to $59.5 million in 2025, then gained by 8.52% to $64.6 million in 2026.
  • Per Business Quant, the three latest ACAD Prepaid Assets figures stand at $64.6 million (Q1 2026), $59.5 million (Q4 2025), and $60.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Acadia Pharmaceuticals 4.23 Bn 3.38 Bn 243.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 64.60 Mn
Dec 31, 2025 59.53 Mn
Sep 30, 2025 60.87 Mn
Jun 30, 2025 52.75 Mn
Mar 31, 2025 52.70 Mn
Dec 31, 2024 55.68 Mn
Sep 30, 2024 51.55 Mn
Jun 30, 2024 46.06 Mn
Mar 31, 2024 42.76 Mn
Dec 31, 2023 39.09 Mn
Sep 30, 2023 37.95 Mn
Jun 30, 2023 23.90 Mn
Mar 31, 2023 23.63 Mn
Dec 31, 2022 21.40 Mn
Sep 30, 2022 22.99 Mn
Jun 30, 2022 20.95 Mn
Mar 31, 2022 25.76 Mn
Dec 31, 2021 23.89 Mn
Sep 30, 2021 24.62 Mn
Jun 30, 2021 26.21 Mn